Terms: = Breast cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
21 results:
1. Construction of an oxidative stress-associated genes signature in breast cancer by machine learning algorithms.
Hu D; Qin B; Zhang L; Bu H
J Int Med Res; 2024 Mar; 52(3):3000605241232560. PubMed ID: 38520254
[TBL] [Abstract] [Full Text] [Related]
2. Identification and validation of N
Li J; Zheng L; Song L; Dong Z; Bai W; Qi L
J Cell Mol Med; 2024 Jan; 28(2):e18067. PubMed ID: 38071502
[TBL] [Abstract] [Full Text] [Related]
3. Dietary Isoflavone Intake and breast cancer prognosis: A Prospective Analysis and Meta-Analysis.
Song S; Cheun JH; Moon HG; Noh DY; Jung SY; Lee ES; Kim Z; Youn HJ; Cho J; Yoo YB; Jun S; Joung H; Lee JE
Nutr Cancer; 2024; 76(1):42-54. PubMed ID: 37943034
[TBL] [Abstract] [Full Text] [Related]
4. CD24-associated ceRNA network reveals prognostic biomarkers in breast carcinoma.
Yu B; Zhao Z; Chen Z; Xiang C; Wang P; Xiao B; Xia Y; Li A; Xiao T; Li H
Sci Rep; 2023 Mar; 13(1):3826. PubMed ID: 36882451
[TBL] [Abstract] [Full Text] [Related]
5. Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients.
Mighri N; Mejri N; Boujemaa M; Berrazega Y; Rachdi H; El Benna H; Labidi S; Benna F; Boubaker S; Boussen H; Abdelhak S; Hamdi Y
PLoS One; 2022; 17(9):e0269732. PubMed ID: 36094928
[TBL] [Abstract] [Full Text] [Related]
6. Clinical impact of pretreatment albumin-globulin ratio in patients with colorectal cancer: A meta-analysis.
Ma JY; Liu G; Pan LZ; Hu M; Zhu ZZ
Medicine (Baltimore); 2022 May; 101(20):e29190. PubMed ID: 35608420
[TBL] [Abstract] [Full Text] [Related]
7. Risk and prognosis of secondary bladder cancer after post-operative radiotherapy for gynecological cancer.
Wen L; Zhong G; Zhang Y; Zhong M
Bosn J Basic Med Sci; 2022 Jun; 22(3):471-480. PubMed ID: 34716699
[TBL] [Abstract] [Full Text] [Related]
8. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract] [Full Text] [Related]
9. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract] [Full Text] [Related]
10. Bcl-3 promotes proliferation and chemosensitivity in BL1 subtype of TNBC cells.
Huo J; Chen X; Zhang H; Hu Y; Jiang Y; Liu S; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1141-1149. PubMed ID: 30289427
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract] [Full Text] [Related]
12. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.
Chen S; Rao H; Liu J; Geng Q; Guo J; Kong P; Li S; Liu X; Sun X; Zhan Y; Xu D
Oncotarget; 2017 Jul; 8(28):45585-45596. PubMed ID: 28489596
[TBL] [Abstract] [Full Text] [Related]
13. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
[TBL] [Abstract] [Full Text] [Related]
14. breast cancer in young women: Pathologic features and molecular phenotype.
Sabiani L; Houvenaeghel G; Heinemann M; Reyal F; Classe JM; Cohen M; Garbay JR; Giard S; Charitansky H; Chopin N; Rouzier R; Daraï E; Coutant C; Azuar P; Gimbergues P; Villet R; Tunon de Lara C; Lambaudie E
Breast; 2016 Oct; 29():109-16. PubMed ID: 27479041
[TBL] [Abstract] [Full Text] [Related]
15. A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive breast cancer.
Bastos EP; Brentani H; Pereira CA; Polpo A; Lima L; Puga RD; Pasini FS; Osorio CA; Roela RA; Achatz MI; Trapé AP; Gonzalez-Angulo AM; Brentani MM
PLoS One; 2016; 11(5):e0154325. PubMed ID: 27152840
[TBL] [Abstract] [Full Text] [Related]
16. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.
Chung YR; Kim H; Park SY; Park IA; Jang JJ; Choe JY; Jung YY; Im SA; Moon HG; Lee KH; Suh KJ; Kim TY; Noh DY; Han W; Ryu HS
Hum Pathol; 2015 Jul; 46(7):1027-35. PubMed ID: 26004371
[TBL] [Abstract] [Full Text] [Related]
17. Heterogeneity in hormone-receptor status and survival outcomes among women with synchronous and metachronous bilateral breast cancers.
Baretta Z; Olopade OI; Huo D
Breast; 2015 Apr; 24(2):131-6. PubMed ID: 25534718
[TBL] [Abstract] [Full Text] [Related]
18. Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
Darb-Esfahani S; von Minckwitz G; Denkert C; Ataseven B; Högel B; Mehta K; Kaltenecker G; Rüdiger T; Pfitzner B; Kittel K; Fiedler B; Baumann K; Moll R; Dietel M; Eidtmann H; Thomssen C; Loibl S
BMC Cancer; 2014 Jul; 14():546. PubMed ID: 25070172
[TBL] [Abstract] [Full Text] [Related]
19. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development.
Naidu R; Har YC; Taib NA
Oncol Res; 2009; 18(2-3):65-71. PubMed ID: 20066896
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of body mass index in locally advanced breast cancer.
Dawood S; Broglio K; Gonzalez-Angulo AM; Kau SW; Islam R; Hortobagyi GN; Cristofanilli M
Clin Cancer Res; 2008 Mar; 14(6):1718-25. PubMed ID: 18347172
[TBL] [Abstract] [Full Text] [Related]
[Next]
